| 产品名称： | Moraxella catarrhalis (Frosch and Kolle) Bovre |
|---|---|
| 商品货号： | TS205007 |
| Deposited As： | Branhamella catarrhalis (Frosch and Kolle) Catlin |
| Strain Designations： | 1908 |
| Application： | Produces beta-lactamase BRO-2 Produces beta-lactamases beta-lactamase, lactamase Susceptibility testing |
| Isolation： | Transtracheal aspirate from coal miner with chronic bronchitis |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 44: Brain Heart Infusion Agar/Broth ATCC® Medium 814: GC Agar/Broth Medium |
| Growth Conditions： | Temperature: 37°C
Atmosphere: 5% CO2 |
| Name of Depositor： | DR Nash |
| Chain of Custody： | ATCC <-- DR Nash <-- C Reading <-- G Ninane |
| References： | Farmer T, Reading C. beta-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid. Antimicrob. Agents Chemother. 21: 506-508, 1982. PubMed: 6980625 Wallace RJ Jr., et al. BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata. Antimicrob. Agents Chemother. 33: 1845-1854, 1989. PubMed: 2514622 Medical microbiology--Susceptibility testing of microbial pathogens to antimicrobial agents -- Part 82: Microdilution; Special requirements for testing of fastidious bacteria. Berlin, Germany:Deutsches Institut fur Normung;DIN DIN 58940-82: 2002, 2002 |
| Cross References： | Nucleotide (GenBank) : Z54181 M.catarrhalis bla gene for BRO-2. |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Moraxella catarrhalis (Frosch and Kolle) Bovre |
|---|---|
| 商品货号： | TS205007 |
| Deposited As： | Branhamella catarrhalis (Frosch and Kolle) Catlin |
| Strain Designations： | 1908 |
| Application： | Produces beta-lactamase BRO-2 Produces beta-lactamases beta-lactamase, lactamase Susceptibility testing |
| Isolation： | Transtracheal aspirate from coal miner with chronic bronchitis |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 44: Brain Heart Infusion Agar/Broth ATCC® Medium 814: GC Agar/Broth Medium |
| Growth Conditions： | Temperature: 37°C
Atmosphere: 5% CO2 |
| Name of Depositor： | DR Nash |
| Chain of Custody： | ATCC <-- DR Nash <-- C Reading <-- G Ninane |
| References： | Farmer T, Reading C. beta-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid. Antimicrob. Agents Chemother. 21: 506-508, 1982. PubMed: 6980625 Wallace RJ Jr., et al. BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata. Antimicrob. Agents Chemother. 33: 1845-1854, 1989. PubMed: 2514622 Medical microbiology--Susceptibility testing of microbial pathogens to antimicrobial agents -- Part 82: Microdilution; Special requirements for testing of fastidious bacteria. Berlin, Germany:Deutsches Institut fur Normung;DIN DIN 58940-82: 2002, 2002 |
| Cross References： | Nucleotide (GenBank) : Z54181 M.catarrhalis bla gene for BRO-2. |
